With HPV rates on the rise in the U.K., researchers are pushing health authorities to include boys in an HPV vaccination program currently offered to females…

Already the world’s best-selling vaccine, Pfizer’s Prevnar 13 got yet another boost Tuesday with an expanded FDA approval in adults aged 18 to 49.

Even as some of the world’s largest drugmakers ante up in the Zika vaccine hunt, some smaller biotechs are looking to play their part in the search for a…

After months of work under the radar, GlaxoSmithKline committed to entering the Zika R&D field, announcing on Thursday that it’s pairing with the National…

Researchers already knew that the protection offered by GlaxoSmithKline’s malaria vaccine--the world’s first--wanes over time. But new data shows it may…

In a study that could provide a needed boost for malaria vaccine research, a team in Australia has blocked P. falciparum parasites from infecting human red…

The Zika virus is spreading in the U.S. with nearly 3,000 infections reported. U.S. funding that could lead to a vaccine to slow the virus is tied up in…

Anticipated to grow to $1.8 billion by 2025, the global meningococcal vaccines market could see some big changes over the next decade. Pending successful late…

Building on previous vaccine collaborations in anthrax and pandemic flu, Gaithersburg, MD-based Emergent BioSolutions is moving its BARDA dealings into the…